# JBT MAREL Corp: overview

JBTM · NYSE · CIK 1433660 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jbtm.md) · [Financials](/companies/jbtm/financials.md) · [Filings](/companies/jbtm/filings.md) · [Insiders](/companies/jbtm/insiders.md)

Latest reported revenue: [$981.0m](/filings/0001628280-26-053548.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053548).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [454](/filings/0001433660-25-000065.md) | [468 d](/filings/0001433660-26-000053.md) | [854](/filings/0001628280-26-030756.md) | [935](/filings/0001628280-26-053548.md) | [1,001](/filings/0001433660-25-000065.md) | [1,008 d](/filings/0001433660-26-000053.md) | [936](/filings/0001628280-26-030756.md) | [981](/filings/0001628280-26-053548.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.3%](/filings/0001433660-25-000065.md) | [3.4% d](/filings/0001433660-26-000053.md) | [(3.9%)](/filings/0001628280-26-030756.md) | [5.1%](/filings/0001628280-26-053548.md) | [10.2%](/filings/0001433660-25-000065.md) | [7.2% d](/filings/0001433660-26-000053.md) | [7.3%](/filings/0001628280-26-030756.md) | [4.7%](/filings/0001628280-26-053548.md) |
| Net margin | % | [8.6%](/filings/0001433660-25-000065.md) | [(1.5%) d](/filings/0001433660-26-000053.md) | [(20.3%)](/filings/0001628280-26-030756.md) | [0.3%](/filings/0001628280-26-053548.md) | [6.6%](/filings/0001433660-25-000065.md) | [5.3% d](/filings/0001433660-26-000053.md) | [4.8%](/filings/0001628280-26-030756.md) | [2.9%](/filings/0001628280-26-053548.md) |
| Diluted EPS | $ per share | [1.21](/filings/0001433660-25-000065.md) | not reported | [(3.35)](/filings/0001628280-26-030756.md) | [0.07](/filings/0001628280-26-053548.md) | [1.26](/filings/0001433660-25-000065.md) | not reported | [0.86](/filings/0001628280-26-030756.md) | [0.54](/filings/0001628280-26-053548.md) |
| Free cash flow | $m | [65.0 d](/filings/0001433660-25-000065.md) | [119 d](/filings/0001433660-26-000053.md) | [14.0](/filings/0001628280-26-030756.md) | [84.0 d](/filings/0001628280-26-053548.md) | [56.6 d](/filings/0001433660-25-000065.md) | [83.5 d](/filings/0001433660-26-000053.md) | [93.0](/filings/0001628280-26-030756.md) | [77.0 d](/filings/0001628280-26-053548.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,401](/filings/0001433660-24-000008.md) | [1,590](/filings/0001433660-25-000009.md) | [1,664](/filings/0001433660-26-000053.md) | [1,716](/filings/0001433660-26-000053.md) | [3,798](/filings/0001433660-26-000053.md) |
| Gross margin | % | [15.7%](/filings/0001433660-23-000007.md) | [16.0%](/filings/0001433660-23-000007.md) | not reported | not reported | not reported |
| Operating margin | % | [9.0%](/filings/0001433660-24-000008.md) | [8.3%](/filings/0001433660-25-000009.md) | [9.9%](/filings/0001433660-26-000053.md) | [6.9%](/filings/0001433660-26-000053.md) | [5.0%](/filings/0001433660-26-000053.md) |
| Net margin | % | [8.5%](/filings/0001433660-24-000008.md) | [8.6%](/filings/0001433660-25-000009.md) | [35.0%](/filings/0001433660-26-000053.md) | [5.0%](/filings/0001433660-26-000053.md) | [(1.3%)](/filings/0001433660-26-000053.md) |
| Diluted EPS | $ per share | [3.71](/filings/0001433660-24-000008.md) | [4.28](/filings/0001433660-25-000009.md) | [18.13](/filings/0001433660-26-000053.md) | [2.65](/filings/0001433660-26-000053.md) | [(0.98)](/filings/0001433660-26-000053.md) |
| Free cash flow | $m | [174](/filings/0001433660-23-000007.md) | [57.7](/filings/0001433660-23-000007.md) | [19.1](/filings/0001433660-26-000053.md) | [195](/filings/0001433660-26-000053.md) | [238](/filings/0001433660-26-000053.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/jbtm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.15bn | 7,932,558 |  | Added +262,918 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $417.7m | 2,880,946 |  | Added +66,659 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $340.3m | 2,346,859 |  | Added +17,009 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $306.7m | 2,115,238 |  | Added +118,083 |
| [UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC](/funds/861177.md) | 2026-06-30 | $263.7m | 1,818,441 |  | Added +143,049 |
| [Lifeyrissjodur verzlunarmanna (Pension Fund of Commerce)](/funds/2139779.md) | 2026-06-30 | $231.3m | 1,595,344 |  | Not compared |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $210.7m | 1,453,124 |  | Added +1,300,364 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $199.6m | 1,376,380 |  | Added +92,775 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $153.6m | 1,059,060 |  | Added +508,190 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $143.0m | 985,898 |  | Reduced −86,559 |

## Recent filings

[All 1,245 filings](/companies/jbtm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 17:20 ET | [10-Q](/filings/0001628280-26-053548.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053548 |
| 2026-08-03 | 16:23 ET | [8-K](/filings/0001628280-26-051894.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051894 |
| 2026-05-19 | 16:14 ET | [8-K](/filings/0001628280-26-036451.md) | 5.07 Shareholder vote results | 0001628280-26-036451 |
| 2026-05-15 | 08:08 ET | [8-K/A](/filings/0001628280-26-035320.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-035320 |
| 2026-05-14 | 16:29 ET | [8-K](/filings/0001628280-26-035145.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-035145 |
| 2026-05-06 | 17:33 ET | [10-Q](/filings/0001628280-26-030756.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030756 |
| 2026-05-04 | 16:55 ET | [8-K](/filings/0001628280-26-029903.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029903 |
| 2026-04-01 | 17:07 ET | [DEF 14A](/filings/0001433660-26-000082.md) | Proxy statement, period 2025-12-31 | 0001433660-26-000082 |
| 2026-03-26 | 08:46 ET | [8-K](/filings/0001433660-26-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001433660-26-000071 |
| 2026-03-02 | 08:41 ET | [10-K](/filings/0001433660-26-000053.md) | Annual report, period 2025-12-31 | 0001433660-26-000053 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001433660-26-000053.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/519abb0f-9986-492b-ac5e-ffdc1e28b14f)

## About the filer

- CIK: 1433660
- Tickers: JBTM
- Exchange: NYSE
- SIC code: 3550 Special Industry Machinery (No Metalworking Machinery)
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.